Literature DB >> 3013779

Killing of Actinobacillus actinomycetemcomitans by the human neutrophil myeloperoxidase-hydrogen peroxide-chloride system.

K T Miyasaki, M E Wilson, R J Genco.   

Abstract

Actinobacillus actinomycetemcomitans is a facultative gram-negative coccobacillus associated with periodontal disease and nonoral infections. This organism is resistant to serum bactericidal mechanisms but is nevertheless killed by human neutrophils under aerobic and anaerobic conditions. Most of the killing attributable to oxidative mechanisms is inhibited by sodium cyanide, which suggests that the myeloperoxidase-hydrogen peroxide-chloride (MPO-H2O2-Cl-) system may be a key factor in the oxidative killing process. In this report, we examine whether the isolated MPO-H2O2-Cl- system is bactericidal against A. actinomycetemcomitans. We found that three major chromatographic forms of MPO were capable of killing A. actinomycetemcomitans at sublethal concentrations of H2O2 and that both catalase-positive and catalase-negative strains of this organism were sensitive to killing by the MPO-H2O2-Cl- system. We conclude that the isolated MPO-H2O2-Cl- system is bactericidal for A. actinomycetemcomitans independent of other neutrophil granule constituents and may be an important component of the oxygen-dependent bactericidal activity of the neutrophil with respect to this periodontopathic organism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013779      PMCID: PMC260091          DOI: 10.1128/iai.53.1.161-165.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  The predominant cultivable organisms in juvenile periodontitis.

Authors:  J Slots
Journal:  Scand J Dent Res       Date:  1976-01

2.  Oxidative autoactivation of latent collagenase by human neutrophils.

Authors:  S J Weiss; G Peppin; X Ortiz; C Ragsdale; S T Test
Journal:  Science       Date:  1985-02-15       Impact factor: 47.728

3.  Microbicidal mechanisms of human granulocytes: synergistic effects of granulocyte elastase and myeloperoxidase or chymotrypsin-like cationic protein.

Authors:  H Odeberg; I Olsson
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

4.  Oxidative and nonoxidative killing of Actinobacillus actinomycetemcomitans by human neutrophils.

Authors:  K T Miyasaki; M E Wilson; A J Brunetti; R J Genco
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

5.  Evidence for and partial characterization of three major and three minor chromatographic forms of human neutrophil myeloperoxidase.

Authors:  K T Miyasaki; M E Wilson; E Cohen; P C Jones; R J Genco
Journal:  Arch Biochem Biophys       Date:  1986-05-01       Impact factor: 4.013

6.  Phagolysosomal pH of human neutrophils.

Authors:  P Cech; R I Lehrer
Journal:  Blood       Date:  1984-01       Impact factor: 22.113

7.  Influence of endogenous catalase activity on the sensitivity of the oral bacterium Actinobacillus actinomycetemcomitans and the oral haemophili to the bactericidal properties of hydrogen peroxide.

Authors:  K T Miyasaki; M E Wilson; J J Zambon; R J Genco
Journal:  Arch Oral Biol       Date:  1985       Impact factor: 2.633

8.  Resistance of Actinobacillus actinomycetemcomitans and differential susceptibility of oral Haemophilus species to the bactericidal effects of hydrogen peroxide.

Authors:  K T Miyasaki; M E Wilson; H S Reynolds; R J Genco
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

9.  Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes.

Authors:  S J Klebanoff
Journal:  Science       Date:  1970-09-11       Impact factor: 47.728

10.  Oxidative peptide cleavage and decarboxylation by the MPO-H2O2-Cl- antimicrobial system.

Authors:  R J Selvaraj; B B Paul; R R Strauss; A A Jacobs; A J Sbarra
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

View more
  8 in total

Review 1.  Role of Nox2 in elimination of microorganisms.

Authors:  Balázs Rada; Csilla Hably; András Meczner; Csaba Timár; Gergely Lakatos; Péter Enyedi; Erzsébet Ligeti
Journal:  Semin Immunopathol       Date:  2008-06-24       Impact factor: 9.623

2.  Role of the capsular polysaccharide-like serotype-specific antigen in resistance of Actinobacillus actinomycetemcomitans to phagocytosis by human polymorphonuclear leukocytes.

Authors:  N Yamaguchi; M Kawasaki; Y Yamashita; K Nakashima; T Koga
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

3.  NADPH Oxidase Contributes to Resistance against Aggregatibacter actinomycetemcomitans-Induced Periodontitis in Mice.

Authors:  Antje Bast; Helen Kubis; Birte Holtfreter; Silvia Ribback; Heiner Martin; Helen C Schreiner; Malte J Dominik; Katrin Breitbach; Frank Dombrowski; Thomas Kocher; Ivo Steinmetz
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

4.  Role of high-avidity binding of human neutrophil myeloperoxidase in the killing of Actinobacillus actinomycetemcomitans.

Authors:  K T Miyasaki; J J Zambon; C A Jones; M E Wilson
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

5.  Oxidative and nonoxidative killing of Actinobacillus actinomycetemcomitans by human neutrophils.

Authors:  K T Miyasaki; M E Wilson; A J Brunetti; R J Genco
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

6.  Effects of anaerobiosis and aerobiosis on interactions of human polymorphonuclear leukocytes with the dental plaque bacteria Streptococcus mutans, Capnocytophaga ochracea, and Bacteroides gingivalis.

Authors:  H L Thompson; J M Wilton
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

7.  Killing of Actinobacillus actinomycetemcomitans by human lactoferrin.

Authors:  J R Kalmar; R R Arnold
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

8.  In vitro antibacterial effect of carbamide peroxide on oral biofilm.

Authors:  Chao Shu Yao; John Douglas Waterfield; Ya Shen; Markus Haapasalo; Michael I Macentee
Journal:  J Oral Microbiol       Date:  2013-06-12       Impact factor: 5.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.